Maryland Capital Management’s Edwards Lifesciences EW Stock Holding History

Maryland Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$23.3M	Sell	281,700 -2,807	-1%	-$270K	1.94%	11
2022 Q2	$27.1M	Sell	284,507 -34,276	-11%	-$3.55M	2.13%	9
2022 Q1	$37.5M	Sell	318,783 -407	-0.1%	-$45.7K	2.35%	8
2021 Q4	$41.4M	Buy	319,190 +13,542	+4%	+$1.58M	2.24%	14
2021 Q3	$34.6M	Buy	+305,648	New	+$34.9M	2.07%	17
2021 Q2	–	Sell	-303,434	Closed	-$25.4M	–	258
2021 Q1	$25.4M	Buy	+303,434	New	+$25.7M	1.7%	20
2020 Q4	–	Sell	-272,117	Closed	-$21.7M	–	225
2020 Q3	$21.7M	Buy	+272,117	New	+$21.2M	1.78%	20
2019 Q4	–	Sell	-196,557	Closed	-$14.4M	–	182
2019 Q3	$14.4M	Buy	196,557 +4,962	+3%	+$349K	1.65%	22
2019 Q2	$11.8M	Buy	191,595 +11,400	+6%	+$689K	1.4%	24
2019 Q1	$11.5M	Buy	180,195 +133,179	+283%	+$7.6M	1.42%	24
2018 Q4	$2.4M	Buy	+47,016	New	+$2.38M	0.35%	63
2017 Q3	–	Sell	-9,000	Closed	-$355K	–	160
2017 Q2	$355K	Hold	9,000	–	–	0.05%	138
2017 Q1	$282K	Hold	9,000	–	–	0.04%	144
2016 Q4	$281K	Hold	9,000	–	–	0.04%	140
2016 Q3	$362K	Hold	9,000	–	–	0.05%	123
2016 Q2	$299K	Hold	9,000	–	–	0.05%	122
2016 Q1	$265K	Hold	9,000	–	–	0.04%	131
2015 Q4	$237K	Hold	9,000	–	–	0.03%	140
2015 Q3	$213K	Hold	9,000	–	–	0.04%	152
2015 Q2	$214K	Hold	9,000	–	–	0.03%	167
2015 Q1	$214K	Buy	+9,000	New	+$202K	0.03%	169

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maryland Capital Management's EW Position: Q3 2022 in Review

Maryland Capital Management reduced its Edwards Lifesciences (EW) stake by 0.99% in Q3 2022, selling an estimated $270K and leaving 281,700 shares worth $23.3M. The position accounts for 1.94% of the portfolio, ranked #11.

Maryland Capital Management first reported a position in EW in Q1 2015 and has held it in 21 quarters since. The position peaked at $41.4M in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Maryland Capital Management held 281,700 shares of Edwards Lifesciences worth $23.3M as of Q3 2022.
Maryland Capital Management sold 2,807 Edwards Lifesciences shares in Q3 2022, an estimated $270K.
Edwards Lifesciences made up 1.94% of Maryland Capital Management's portfolio in Q3 2022, its #11 holding.
Maryland Capital Management first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 21 quarters since.
Maryland Capital Management's Edwards Lifesciences position peaked at $41.4M in Q4 2021.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.